AKRFF yields 2063.98% · PFE yields 6.13%● Live data
📍 AKRFF pulled ahead of the other in Year 1
Combined, AKRFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AKRFF + PFE for your $10,000?
Ackroo Inc. develops and sells an online loyalty and rewards platform that enables businesses to design and execute customer transaction, engagement, and retention strategies primarily in North America. It enables small to medium sized businesses to automate the processing and management of gift card and loyalty transactions to increase profitability and build long-term customer relationships. The company's cloud-based marketing platform provides merchants an in-store and online process to manage loyalty, gift card, and promotional transactions at the point of sale; a program to help them view data for reconciliation, reporting, and marketing; and customer interfaces to allow merchant's consumers to register, check, transfer, and reload balances. It also provides AckrooPOS/GGGolf platform for golf clubs, which integrates accounting and hospitality point of sale options and other services; and offers handicapping services, as well as to manage tee-sheets, lottery, and tournaments. In addition, the company offers marketing services, including email and direct mail marketing, and design services; and payment services comprising credit and debit card processing services. It serves automotive, petroleum, hospitality, and retail markets. Ackroo Inc. was founded in 2012 and is headquartered in Hamilton, Canada.
Full AKRFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.